Vor Biopharma Inc

Research Vor Biopharma Inc (VOR) on Bullrun: market cap USD 1.01B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerVOR
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.01B
• Financial periodFY2025
• Net income-USD 695.98M
• Free cash flow-USD 143.65M

Valuation Snapshot

latest market cap is USD 1.01B.

About Vor Biopharma Inc

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products.

Frequently asked questions

What is Vor Biopharma Inc's market cap?

Vor Biopharma Inc's market capitalization is USD 1.01B.

What does Vor Biopharma Inc do?

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases.